Skip main navigation (Press Enter).
Log in
Toggle navigation
Search Options
Log in
Home
About
About ISOP
History
Governance
Leadership
Awards
Fellows
Sponsors
Contact Us
Donate to ISoP
Membership
Key Benefits
Membership Categories
Global Community
Trainee Community
Annual Conference
Learning Center
Resources
Standards
Career Center
Tools
Regulatory
Special Interest Groups
Search Options
A Novel and Innovative Model-Based Approach to Identify the Approved Posology for Mavacamten in Obst
×
More information
When:
Aug 21, 2024 from 12:00 to 13:00 (ET)
Download to Your Calendar
Location
Online Instructions:
Url:
http://learn.isop.org/products/a-novel-and-innovative-model-based-approach-to-identify-the-approved-posology-for-mavacamten-in-obstructive-hypertrophic-cardiomyopathy-hcm
Login:
Other Upcoming Webinars and Events
IV-SC Bridging Based on Pharmacodynamic Endpoints: How Can MIDD Help
Oct 23, 12:00 - 13:00 (ET)
ACoP2024
Nov 10 - 13, (PT)
Long Lasting Injectables, Shorter Path to Approval
Nov 20, 12:00 - 13:00 (ET)
How to Prepare for a Successful MIDD Meeting with the FDA
Dec 18, 12:00 - 13:00 (ET)
Copyright © 2024 International Society of Pharmacometrics. All Rights Reserved.
Powered by Higher Logic